Wednesday, July 31, 2013

RPG LIFE SCIENCES LTD - RESULTS - FOR Q1 FY 2013-14 - Q.E. JUNE 2013 - IMPROVED PERFORMANCE - FDA APPROVAL YET TO COME




RPG LIFE SCIENCES LIMITED

QUARTERLY RESULTS FOR  Q1 FY 2013-14

Q/E JUNE 2013


RPG LIFE SCIENCES has produced improved results for the first quarter ending June, 2013.

The results are analysed below :

Net Sales for Q1 FY 14 stand at Rs.62.90 Cr, up by 11.64% from Q4 FY 13(Rs.56.34 Cr); and up by 14.95% from Q1 FY 13 (Rs.54.72 cr).

The company says :

Subsequent to the pre-approval inspection of the company's API facility at Navi Mumbai and formulation facility at Ankleshwar by USFDA, the company has received a notice of non-compliance from USFDA during the quarter. The company has duly responded to the said notice. However, there is no immediate business impact of this event as the company does not have any exports to USA.

Total Income    for Q1 FY 14 stand at Rs.64.18 Cr, up by 9.88% from Q4 FY 13(Rs.58.41 Cr); and up by 15.04% from Q1 FY 13 (Rs.   55.79 cr).

Cost of materials       for Q1 FY 14 stand at Rs.19.10 Cr, up by 57.59% from Q4 FY 13 (Rs.12.12 Cr); and up by 40.96% from Q1 FY 13 (Rs.13.55 cr).Cost of Materials has gone up hugely compared to sales.

Purchases of stock-in-trade       for Q1 FY 14 stand at Rs.4.49         Cr, up by 5.65% from Q4 FY 13(Rs.4.25 Cr); and up by     25.07% from Q1 FY 13 (Rs.3.59 cr).
Employee benefits expense        for Q1 FY 14 stand at Rs.14.72 Cr, up by8.96% from Q4 FY 13(Rs.13.51 Cr); and up by 19.97% from Q1 FY 13 (Rs.   12.27 cr).

Depreciation     for Q1 FY 14 stand at Rs.2.54 Cr, up by  0.4% from Q4 FY 13(Rs.2.53 Cr); and up by        7.17% from Q1 FY 13 (Rs.2.37 cr).

Other expenses for Q1 FY 14 stand at Rs.20.95 Cr, up by 23.96% from Q4 FY 13(Rs.16.90 Cr); and up by 13.24% from Q1 FY 13 (Rs.18.50 cr).

Total Expenditure      for Q1 FY 14 stand at Rs.58.30 Cr, up by 8.53% from Q4 FY 13(Rs.53.72 Cr); and up by  12.81% from Q1 FY 13 (Rs.51.68 cr). Total expenditure has grown but less than proportionately compared to Sales income and total income.

Profit before Interest, Dep. & Taxes for Q1 FY 14 stand at Rs.4.60 Cr, up by 75.57 % from Q4 FY 13(Rs.2.62 Cr); and up by 51.32% from Q1 FY 13 (Rs.3.04 cr).

Exceptional Income comprises of profit of Rs. 61.84 Cr on sale of a portion of leasehold land and building thereon and the company's share of interest income of Rs. 2.42 Cr earned on the sale consideration deposited by the buyer in an escrow account.

Profit before tax        for Q1 FY 14 stand at Rs.69.37 Cr, up by         1865.16% from Q4 FY 13(Rs.3.53 Cr); and up by 2334.04% from Q1 FY 13 (Rs.2.85 cr).

Tax Expenses    for Q1 FY 14 stand at Rs.14.68 Cr, compared to Rs.-3.87 Cr in Q4 FY 13; and Rs.0.06 cr in Q1 FY 13.

Net Profit  for Q1 FY 14 stand at Rs.54.69 Cr, up by 639.05% from Q4 FY 13(Rs.7.40 Cr); and up by 1860.22% from Q1 FY 13 (Rs.2.79 cr).

Face Value- stands at Rs.8/-

Paid-up Equity for Q1 FY 14 stand at Rs.13.23 Cr

Basic EPS for Q1 FY 14 stand at Rs.33.07 ,compared to Rs.4.48 in previous Qtr and Rs.1.69 in corresponding Qtr of last year.

Public Shareholding (%) for Q1 FY 14 stand at Rs.43.52

Dividend Declared :    RS 1.20/- PER SHARE

RESULTS TABLE

RPG LIFE SCIENCES
30-Jun-13
%DIF QoQ
31-Mar-13
31-Dec-12
30-Sep-12
%DIF YoY
30-Jun-12
Net Sales
6290
11.64
5634
4809
5706
14.95
5472
Total Expenditure
5830
8.53
5372
5388
5616
12.81
5168
Profit before Interest, Dep. & Taxes
460
75.57
262
-579
90
51.32
304
Net Profit
5469
639.05
740
-609
31
1860.22
279
Diluted EPS
33.07
638.17
4.48
-3.68
0.18
1856.8
1.69
Net Sales
6290
11.64
5634
4809
5706
14.95
5472
Total Income
6418
9.88
5841
4901
5843
15.04
5579
Changes in inventories
-350
-179.37
441
40
-352
-350
140
Cost of materials
1910
57.59
1212
1359
1553
40.96
1355
Purchases of stock-in-trade
449
5.65
425
411
685
25.07
359
Employee benefits expense
1472
8.96
1351
1391
1551
19.97
1227
Depreciation
254
0.4
253
257
240
7.17
237
Other expenses
2095
23.96
1690
1930
1939
13.24
1850
Total expenses
5830
8.53
5372
5388
5616
12.81
5168
Profit before tax
6937
1865.16
353
-635
51
2334.04
285
Tax Expenses
1468
-479.33
-387
-26
20
24366.67
6
Net Profit
5469
639.05
740
-609
31
1860.22
279
Face Value-Rs
8
0
8
8
8
0
8
Paid-up Equity
1323
0
1323
1323
1323
0
1323
Basic EPS
33.07
638.17
4.48
-3.68
0.18
1856.8
1.69
Public Shareholding (%)
43.52
0
43.52
43.52
43.52
-7.21
46.9


 *  *  *  E  N  D  *  *  *